Print

GlaxoSmithKline (GSK) Launches Hepsera Oral Antiviral Drug For Chronic Hepatitis B Infection 
10/19/2005 5:12:25 PM

GlaxoSmithKline (GSK) announced December 8 that it has launched Hepsera 10, an oral antiviral drug used in the treatment for chronic hepatitis B infection.
//-->